China Darunavir Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Darunavir (DRV), sold under the brand name Prezista among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Darunavir market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Darunavir market. Detailed analysis of key players, along with key growth strategies adopted by Darunavir industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Lupin

    • Mylan

    • Cipla

    • Teva

    • Hetero

    • Janssen Therapeutics

    By Type:

    • Tablet

    • Oral Suspension

    By End-User:

    • Hospital

    • Drug Stores

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Darunavir Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Darunavir Market Size and Growth Rate of Tablet from 2016 to 2027

    • 1.3.2 China Darunavir Market Size and Growth Rate of Oral Suspension from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Darunavir Market Size and Growth Rate of Hospital from 2016 to 2027

    • 1.4.2 China Darunavir Market Size and Growth Rate of Drug Stores from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Darunavir Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Darunavir Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Darunavir Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Darunavir Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Darunavir Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Darunavir Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Darunavir Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Darunavir Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Darunavir by Major Types

    • 3.4.1 Market Size and Growth Rate of Tablet

    • 3.4.2 Market Size and Growth Rate of Oral Suspension

    4 Segmentation of Darunavir Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Darunavir by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Darunavir in Hospital

    • 4.4.2 Market Size and Growth Rate of Darunavir in Drug Stores

    5 Market Analysis by Regions

    • 5.1 China Darunavir Production Analysis by Regions

    • 5.2 China Darunavir Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Darunavir Landscape Analysis

    • 6.1 North China Darunavir Landscape Analysis by Major Types

    • 6.2 North China Darunavir Landscape Analysis by Major End-Users

    7 Central China Darunavir Landscape Analysis

    • 7.1 Central China Darunavir Landscape Analysis by Major Types

    • 7.2 Central China Darunavir Landscape Analysis by Major End-Users

    8 South China Darunavir Landscape Analysis

    • 8.1 South China Darunavir Landscape Analysis by Major Types

    • 8.2 South China Darunavir Landscape Analysis by Major End-Users

    9 East China Darunavir Landscape Analysis

    • 9.1 East China Darunavir Landscape Analysis by Major Types

    • 9.2 East China Darunavir Landscape Analysis by Major End-Users

    10 Northeast China Darunavir Landscape Analysis

    • 10.1 Northeast China Darunavir Landscape Analysis by Major Types

    • 10.2 Northeast China Darunavir Landscape Analysis by Major End-Users

    11 Southwest China Darunavir Landscape Analysis

    • 11.1 Southwest China Darunavir Landscape Analysis by Major Types

    • 11.2 Southwest China Darunavir Landscape Analysis by Major End-Users

    12 Northwest China Darunavir Landscape Analysis

    • 12.1 Northwest China Darunavir Landscape Analysis by Major Types

    • 12.2 Northwest China Darunavir Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Lupin

      • 13.1.1 Lupin Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Mylan

      • 13.2.1 Mylan Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Cipla

      • 13.3.1 Cipla Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Teva

      • 13.4.1 Teva Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Hetero

      • 13.5.1 Hetero Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Janssen Therapeutics

      • 13.6.1 Janssen Therapeutics Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Darunavir Market Size and Growth Rate of Tablet from 2016 to 2027

    • Figure China Darunavir Market Size and Growth Rate of Oral Suspension from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Darunavir Market Size and Growth Rate of Hospital from 2016 to 2027

    • Figure China Darunavir Market Size and Growth Rate of Drug Stores from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Darunavir Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Darunavir Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Darunavir Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Darunavir Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Darunavir Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Darunavir Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Darunavir Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Darunavir Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Darunavir

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Darunavir by Different Types from 2016 to 2027

    • Table Consumption Share of Darunavir by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Tablet

    • Figure Market Size and Growth Rate of Oral Suspension

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Darunavir by Different End-Users from 2016 to 2027

    • Table Consumption Share of Darunavir by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Drug Stores

    • Table China Darunavir Production by Regions

    • Table China Darunavir Production Share by Regions

    • Figure China Darunavir Production Share by Regions in 2016

    • Figure China Darunavir Production Share by Regions in 2021

    • Figure China Darunavir Production Share by Regions in 2027

    • Table China Darunavir Consumption by Regions

    • Table China Darunavir Consumption Share by Regions

    • Figure China Darunavir Consumption Share by Regions in 2016

    • Figure China Darunavir Consumption Share by Regions in 2021

    • Figure China Darunavir Consumption Share by Regions in 2027

    • Table North China Darunavir Consumption by Types from 2016 to 2027

    • Table North China Darunavir Consumption Share by Types from 2016 to 2027

    • Figure North China Darunavir Consumption Share by Types in 2016

    • Figure North China Darunavir Consumption Share by Types in 2021

    • Figure North China Darunavir Consumption Share by Types in 2027

    • Table North China Darunavir Consumption by End-Users from 2016 to 2027

    • Table North China Darunavir Consumption Share by End-Users from 2016 to 2027

    • Figure North China Darunavir Consumption Share by End-Users in 2016

    • Figure North China Darunavir Consumption Share by End-Users in 2021

    • Figure North China Darunavir Consumption Share by End-Users in 2027

    • Table Central China Darunavir Consumption by Types from 2016 to 2027

    • Table Central China Darunavir Consumption Share by Types from 2016 to 2027

    • Figure Central China Darunavir Consumption Share by Types in 2016

    • Figure Central China Darunavir Consumption Share by Types in 2021

    • Figure Central China Darunavir Consumption Share by Types in 2027

    • Table Central China Darunavir Consumption by End-Users from 2016 to 2027

    • Table Central China Darunavir Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Darunavir Consumption Share by End-Users in 2016

    • Figure Central China Darunavir Consumption Share by End-Users in 2021

    • Figure Central China Darunavir Consumption Share by End-Users in 2027

    • Table South China Darunavir Consumption by Types from 2016 to 2027

    • Table South China Darunavir Consumption Share by Types from 2016 to 2027

    • Figure South China Darunavir Consumption Share by Types in 2016

    • Figure South China Darunavir Consumption Share by Types in 2021

    • Figure South China Darunavir Consumption Share by Types in 2027

    • Table South China Darunavir Consumption by End-Users from 2016 to 2027

    • Table South China Darunavir Consumption Share by End-Users from 2016 to 2027

    • Figure South China Darunavir Consumption Share by End-Users in 2016

    • Figure South China Darunavir Consumption Share by End-Users in 2021

    • Figure South China Darunavir Consumption Share by End-Users in 2027

    • Table East China Darunavir Consumption by Types from 2016 to 2027

    • Table East China Darunavir Consumption Share by Types from 2016 to 2027

    • Figure East China Darunavir Consumption Share by Types in 2016

    • Figure East China Darunavir Consumption Share by Types in 2021

    • Figure East China Darunavir Consumption Share by Types in 2027

    • Table East China Darunavir Consumption by End-Users from 2016 to 2027

    • Table East China Darunavir Consumption Share by End-Users from 2016 to 2027

    • Figure East China Darunavir Consumption Share by End-Users in 2016

    • Figure East China Darunavir Consumption Share by End-Users in 2021

    • Figure East China Darunavir Consumption Share by End-Users in 2027

    • Table Northeast China Darunavir Consumption by Types from 2016 to 2027

    • Table Northeast China Darunavir Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Darunavir Consumption Share by Types in 2016

    • Figure Northeast China Darunavir Consumption Share by Types in 2021

    • Figure Northeast China Darunavir Consumption Share by Types in 2027

    • Table Northeast China Darunavir Consumption by End-Users from 2016 to 2027

    • Table Northeast China Darunavir Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Darunavir Consumption Share by End-Users in 2016

    • Figure Northeast China Darunavir Consumption Share by End-Users in 2021

    • Figure Northeast China Darunavir Consumption Share by End-Users in 2027

    • Table Southwest China Darunavir Consumption by Types from 2016 to 2027

    • Table Southwest China Darunavir Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Darunavir Consumption Share by Types in 2016

    • Figure Southwest China Darunavir Consumption Share by Types in 2021

    • Figure Southwest China Darunavir Consumption Share by Types in 2027

    • Table Southwest China Darunavir Consumption by End-Users from 2016 to 2027

    • Table Southwest China Darunavir Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Darunavir Consumption Share by End-Users in 2016

    • Figure Southwest China Darunavir Consumption Share by End-Users in 2021

    • Figure Southwest China Darunavir Consumption Share by End-Users in 2027

    • Table Northwest China Darunavir Consumption by Types from 2016 to 2027

    • Table Northwest China Darunavir Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Darunavir Consumption Share by Types in 2016

    • Figure Northwest China Darunavir Consumption Share by Types in 2021

    • Figure Northwest China Darunavir Consumption Share by Types in 2027

    • Table Northwest China Darunavir Consumption by End-Users from 2016 to 2027

    • Table Northwest China Darunavir Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Darunavir Consumption Share by End-Users in 2016

    • Figure Northwest China Darunavir Consumption Share by End-Users in 2021

    • Figure Northwest China Darunavir Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Lupin

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lupin

    • Figure Sales and Growth Rate Analysis of Lupin

    • Figure Revenue and Market Share Analysis of Lupin

    • Table Product and Service Introduction of Lupin

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of Cipla

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla

    • Figure Sales and Growth Rate Analysis of Cipla

    • Figure Revenue and Market Share Analysis of Cipla

    • Table Product and Service Introduction of Cipla

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva

    • Table Company Profile and Development Status of Hetero

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hetero

    • Figure Sales and Growth Rate Analysis of Hetero

    • Figure Revenue and Market Share Analysis of Hetero

    • Table Product and Service Introduction of Hetero

    • Table Company Profile and Development Status of Janssen Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Therapeutics

    • Figure Sales and Growth Rate Analysis of Janssen Therapeutics

    • Figure Revenue and Market Share Analysis of Janssen Therapeutics

    • Table Product and Service Introduction of Janssen Therapeutics


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.